On July 1, 2019, a Parent Company, Located in France

On July 1, 2019, a parent company, located in France, acquired the outstanding shares of a subsidiary located in Hong Kong for HK$20,000 in cash. The entire excess of acquisition cost over the subsidiary's book value was attributed to goodwill. The subsidiary's functional currency is the Hong Kong dollar (HK$). The parent company uses the complete equity method to report its investment in the subsidiary on its own books, and the accounting year for both companies ends June 30. The June 30, 2020, trial balances of the parent and subsidiary are below.
$\begin{array}{|l|c|c|}\hline & \begin{array}{l}\text { Parent } \\\text { Dr (Cr) }\end{array} & \begin{array}{c}\text { Subsidiary } \\\text { Dr (a) }\end{array} \\\hline \text { Current assets } & € \quad 4,000 & \mathrm{HK} \$ \quad 2,000 \\\hline \text { Plant assets, net } & 120,000 & 85,000 \\\hline \text { Investment in subsidiary } & 2,071 & - \\\hline \text { Liabilities } & (113,700) & (85,300) \\\hline \text { Capital stock } & (2,000) & (500) \\\hline \text { Retained earning } s \text {, July } 1 & (10,000) & (1, \infty) \\\hline \text { Sales revenue } & (25,000) & (8,000) \\\hline \text { Equity in net income of subsidiary } & \text { (24) } & - \\\hline \text { Equity in } \mathrm{OCl} \text { of subsidiary } & \text { (47) } & - \\\hline \text { Expenses } & 24,700 & 7,800 \\\hline \text { Total } &?\quad0 & \text { HKS }\quad0 \\\hline\end{array}$
$$\begin{array}{l}\text { Exchange rates are as follows: }\\\begin{array} { | l | r | } \hline \text { July } 1,2019 & ? 0.10 / \mathrm { HK } \$ \\\hline \text { Average for fiscal } 2020 & 0.12 / \mathrm { HK } \$ \\\hline \text { June } 30,2020 & 0.13 / \mathrm { HK } \$ \\\hline\end{array}\end{array}$$ Goodwill arising from this acquisition was not impaired in fiscal 2020.
Required
a. Translate the subsidiary's June 30, 2020, trial balance into euros, the presentation currency of its parent.
b. Prepare a working paper to consolidate the June 30, 2020, trial balances of the parent and its subsidiary.